Various medicinal products
Original title: Biosimilars: Infliximab IV, Tocilizumab IV en SC, Denosumab SC en Epoëtine alfa
| Country | Belgium |
|---|---|
| Deadline | 2026-12-01 (10 days left) |
| Published | 2026-11-03 |
| Sectors | Health & life sciences |
| Source | TED - Tenders Electronic Daily (EU) |
Summary
INFLIXIMAB IV
The buyer, the value, the full description and the link to the official notice are available with a free account.